Arvinas ARVN
NASDAQ ARVN
$7.43 -0.31 (-3.94%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026)

Updated

Arvinas' Return on Equity [ROE] came in at 1.96% for Q2 2026, up 13.40 percentage points from -11.44% a year earlier and up 55.89 percentage points from the prior quarter.

Analysis

Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, Arvinas' Return on Equity [ROE] was -16.23%, up 16.33 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of +10.29 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -32.56% in FY2024 (+27.00 pp), -59.56% in FY2023 (-19.18 pp), -40.38% in FY2022 (-14.52 pp) and -25.86% in FY2021 (+0.66 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] in data going back to Q1 2019.
  • Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +19.91 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 48.04 percentage points), and the weakest in Q1 2026 (a drop of 46.30 percentage points).
  • Business Quant data shows ARVN's Return on Equity [ROE] at -53.93% (Q1 2026), -16.19% (Q4 2025) and -9.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Arvinas 505.42 Mn -2.15 Bn - 1.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.96%
Mar 31, 2026 -53.93%
Dec 31, 2025 -16.19%
Sep 30, 2025 -9.97%
Jun 30, 2025 -11.44%
Mar 31, 2025 -7.63%
Dec 31, 2024 -34.66%
Sep 30, 2024 -52.03%
Jun 30, 2024 -53.44%
Mar 31, 2024 -55.67%
Dec 31, 2023 -65.31%
Sep 30, 2023 -63.01%
Jun 30, 2023 -59.41%
Mar 31, 2023 -54.22%
Dec 31, 2022 -45.85%
Sep 30, 2022 -36.84%
Jun 30, 2022 -31.78%
Mar 31, 2022 -27.15%
Dec 31, 2021 -23.03%
Sep 30, 2021 -25.26%
API Access

Arvinas Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEY